Long term survival in a case of concurrent retroperitoneal liposarcoma and renal cell carcinoma: a case report
BMC Research Notes volume 7, Article number: 538 (2014)
Liposarcoma is one of the most common soft tissue sarcomas found in adults. It has a predilection for retroperitoneal space. Renal cell carcinoma is the most common tumor of the kidney.
Concurrent retroperitoneal liposarcoma and renal cell carcinoma were found in a 34-year-old Japanese man. The renal tumor was first detected by ultrasonography, it was confirmed by computed tomography, which also identified a presumptive retroperitoneal liposarcoma, and the tumors were further assessed with magnetic resonance imaging. The patient was treated by surgical resection of retroperitoneal liposarcoma and left nephrectomy and has been disease-free for 10 years.
The concomitant occurrence of a renal tumor and a primary primary liposarcoma is rare. The major factors promoting a good prognosis in this case were the favorable histology and the small size of the tumors.
Liposarcoma is one of the most common soft tissue sarcomas found in adults, and it usually occurs in the retroperitoneum and the extremities . Its incidence rate increases in middle-aged and older adults with a peak in 70–80 year olds. Renal cell carcinoma (RCC) is the most common tumor of the kidney. Its incidence is highest in those aged 50–70 years. The co-occurence of RCC and hematological malignancies as well as solid tumors has been reported.
A 34-year-old Japanese man, with no significant previous medical history, presented to our hospital because of an incidentally detected renal tumor. The patient did not have a family history of RCC or any signs of hereditary RCC syndrome on examination. He did not have any physical and laboratory findings indicating RCC including microscopic hematuria. Contrast enhanced computed tomography (CT) (Figure 1A) confirmed a 2.5 cm left kidney tumor; it showed the early enhancement and washout typical of a clear cell RCC. Additionally, a retroperitoneal tumor with calcification was identified, the presence of lipid and soft tissue components was confirmed, and a presumptive diagnosis of retroperitoneal liposarcoma was made (Figure 1A). Abdominal magnetic resonance imaging (MRI) (Figure 1B, C) showed a tumor located in the interaortocaval space with high signal intensity on the T2-weighted images. No apparent metastases were identified.Left partial nephrectomy and resection of the retroperitoneal tumor were performed in September 2003. The pathological diagnoses were clear cell renal carcinoma and retroperitoneal liposarcoma (Figure 2). The excised retroperitoneal tumor was a 6.8 × 4.8 cm well-circumscribed mass. Cut sections of the tumor had a lobulated yellowish appearance. Histological examination revealed the tumor to be composed of a mixture of fibrous tissue and mature-appearing adipose tissues (Figure 2C), with the fibrous tissue separation the adipose tissue into regions of varied size. The adipose cells appeared almost mature, but the tumor contained atypical cells with varied size and shape, including a few mono- or mutli-vacuolated lipoblastic cells. The fibrous tissues contained muscle fibers. Few cells were positive for MIB-1 antibody (proliferating cells). The resected renal tumor was 1.6 × 1.6 cm in size, histopathology showed a clear cell RCC (Figure 2D) circumscribed by a fibrous capsule, classified as G1 pT1a (i.e. less than 4 cm in size and confined to the kidney). Surgical margins of both tumors were negative and no adjuvant treatment was performed. Ten years after the operation, the patient is doing well and has not experienced a recurrence.
Young patient age can indicate a hereditary RCC syndrome. However, our patient had no family history and clinical signs of tuberous sclerosis, von Hippel-Lindau disease, and succinate dehydrogenase-associated familial cancer.
We identified five reported cases of concurrent liposarcoma and RCC [2–6] (Table 1). Patients age ranged from 58 to 79 years (median 71 years), slightly older than the average age for all RCC patients. The RCC histological subtype was clear cell in 1 case , papillary cell in 3 cases [2, 3, 6] and granular cell in 1 case  (note: it has recently been shown that “granular cell” type RCC is not an independent histological type). The location of liposarcoma was perirenal [4, 5] in 2 cases, retroperitoneal [2, 6] in 2 cases, and cardiac  in 1 case (found by autopsy). Although the number of reported cases is small, it is interesting to note that only one case represented the clear cell subtype whereas three cases were diagnosed as papillary cell RCC. In the present case retroperitoneal liposarcoma was located in interaortocaval space and RCC histology was clear cell. Our case and all of the previously reported cases were males, which fits with the male predisposition for RCC.
In addition to the previously described cases, we found two published case reports regarding liposarcomatous differentiation in chromophobe RCCs [7, 8]. In contrast, the renal tumor in our case was a typical clear cell RCC, and the two tumors represented distinct entities.
Over the last 15 years, 1123 patients with retroperitoneal soft tissue sarcoma have been reported in 25 series; these tumors had a mean diameter of 15.7 cm . Retroperitoneal soft tissue sarcomas represent 0.10 to 0.15% of all malignancies and 45% of all retroperitoneal tumors. Because of the localization, symptoms are nonspecific (e.g., abdominal discomfort and palpable mass) and caused by tumor growth, which is typically very large when detected. The only curative treatment modality is complete surgical resection; chemotherapy and radiation therapy show no survival benefit. It has been reported that 51.4% of these tumors can be completely excised and that 50.2% of these excisions include adjacent organs . The prognosis without complete excision is poor with reported 5- and 10-year survival rates of 16.7% and 8.0% respectively .
Local recurrence represents the major type of progression for retroperitoneal liposarcomas. Yamamoto et al. described 45 patients with well-differentiated liposarcoma who underwent surgical treatment. Among 41 patients who underwent initial surgery, only one recurrence occurred, which was localized in the retroperitoneal space. For 4 patients who underwent a reoperation, the mean time between the initial surgery and the recurrence was 16.5 years. None of the 45 patients developed distant metastasis. In our case, during the 10 years of follow-up to date, no recurrence or metastasis has been detected. However, continued follow-up is necessary because late recurrences are common with liposarcoma.
Previously reported liposarcomas have demonstrated heterogeneous signal intensity on MRI with great variation depending on the components and histological patterns of a particular tumor. Retroperitoneal liposarcomas have been classified into several clinico-pathological subtypes . Myxoid liposarcoma, consisting of a myxoid matrix and a small amount of mature fat, shows low signal intensity on T1 weighted image and high signal intensity on T2 weighted image . Well-differentiated liposarcoma presented high signal intensity on T1 weighted images, intermediate signal intensity on T2 weighted images, drop-out signal intensity on fat-suppressed MR images . Round-cell liposarcoma and pleomorphic liposarcoma exhibit the signal intensity of a soft-tissue tumor without a characteristic fat signal . Liposarcomas can present with intratumoral hemorrhage and may invade adjacent organs. In the present case, the tumor showed high signal intensity on the T2-weighted images, which is typical for myxoid liposarcoma and is inconsistent with well-differentiated liposarcoma which was diagnosed pathologically. Five-year and ten-year disease specific survival is the highest for well-differentiated liposarcoma (100% and 87%) followed by myxoid liposarcoma (88% and 76%), and is the lowest for pleomorphic liposarcoma (56% and 39%) (http://sarcomahelp.org/liposarcoma.html).
We have presented a case of concomitant RCC and retroperitoneal liposarcoma in a young male. Although no data exists regarding an association between these two malignant tumors, a genetic predisposition for cancer is likely present given patient’s young age. Both tumors were completely surgically excised and no relapse has been seen during ten-year follow-up to date. The major factors promoting a good prognosis in this case were favorable histology and small size of the tumors at initial diagnosis.
Written informed consent was obtained from the patient for publication of this Case Report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Tsuruta A, Notohara K, Park T, Itoh T: Dedifferentiated liposarcoma of the rectum: a case report. World J Gastroenterol. 2012, 18 (41): 5979-5981. 10.3748/wjg.v18.i41.5979.
Frank RM, Velasco JM: Surgical management of incidental renal tumor during excision of retroperitoneal liposarcoma and osteogenic sarcoma. Am Surg. 2013, 79 (2): E88-E90.
Galazka K, Ciezarek M, Soja J, Krzanowski M, Szlubowski A, Sydor K, Adamczyk W, Grodecki J, Sladek K: Synchronous primary heart liposarcoma and papillary renal carcinoma–a case report. Pol J Pathol. 2003, 54 (2): 153-159.
Kinebuchi Y, Ishizuka O, Minagawa T, Nisizawa O, Shimojo H: Concurrent perirenal liposarcoma associated with renal cell carcinoma. Hinyokika Kiyo. 2009, 55 (9): 571-574.
Lewis DJ, Moul JW, Williams SC, Sesterhenn IA, Colon E: Perirenal liposarcoma containing extramedullary hematopoiesis associated with renal cell carcinoma. Urology. 1994, 43 (1): 106-109. 10.1016/S0090-4295(94)80279-3.
Williamson JM, Konig TC, Canelo R: Incidental finding of renal cell carcinoma in recurrent retroperitoneal liposarcoma. Ann R Coll Surg Engl. 2008, 90 (1): W4-W5.
Anila KR, Mathew AP, Somanathan T, Mathews A, Jayasree K: Chromophobe renal cell carcinoma with heterologous (Liposarcomatous) differentiation: a case report. Int J Surg Pathol. 2011, 20 (4): 416-419.
Petersson F, Michal M, Franco M, Hes O: Chromophobe renal cell carcinoma with liposarcomatous dedifferentiation - report of a unique case. Int J Clin Exp Pathol. 2010, 3 (5): 534-540.
Bradley JC, Caplan R: Giant retroperitoneal sarcoma: a case report and review of the management of retroperitoneal sarcomas. Am Surg. 2002, 68 (1): 52-56.
Yamamoto N, Hayashi K, Tanzawa Y, Kimura H, Takeuchi A, Igarashi K, Inatani H, Shimozaki S, Kitamura S, Tsuchiya H: Treatment strategies for well-differentiated liposarcomas and therapeutic outcomes. Anticancer Res. 2012, 32 (5): 1821-1825.
Song T, Shen J, Liang BL, Mai WW, Li Y, Guo HC: Retroperitoneal liposarcoma: MR characteristics and pathological correlative analysis. Abdom Imaging. 2007, 32 (5): 668-674. 10.1007/s00261-007-9220-6.
The authors would like to express their gratitude to Edanz (Edanz Group Japan) for editing the manuscript by a native-English speaker with scientific expertise.
The authors declare that they have no competing interests.
SH, NH, MY, TO, AM, OS, KN, KH, and SS made substantial contributions to conception, acquisition of data; SH and VB have been involved in analysis and interpretation of data, drafting and revising the manuscript; IS conceived of the study, interpreted the data; SH and IS have given final approval of the version to be published. All authors read and approved the final manuscript.
About this article
Cite this article
Hoshi, S., Hayashi, N., Yagi, M. et al. Long term survival in a case of concurrent retroperitoneal liposarcoma and renal cell carcinoma: a case report. BMC Res Notes 7, 538 (2014). https://doi.org/10.1186/1756-0500-7-538